Delisting of Securities of AtheroGenics (AGIX) From The NASDAQ Stock Market
3/26/2009 9:13:51 AM
NEW YORK, March 25, 2009 (GLOBE NEWSWIRE) -- The NASDAQ Stock Market announced today that it will delist the common stock of AtheroGenics, Inc. AtheroGenics, Inc.'s stock was suspended on October 14, 2008 and has not traded on NASDAQ since that time. NASDAQ will file a Form 25 with the Securities and Exchange Commission to complete the delisting. The delisting becomes effective ten days after the Form 25 is filed. For news and additional information about the company, including the basis for the delisting and whether the company's securities are trading on another venue, please review the company's public filings or contact the company directly.
comments powered by